A detailed history of Houlihan Financial Resource Group, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Houlihan Financial Resource Group, Ltd. holds 504 shares of LLY stock, worth $377,959. This represents 0.18% of its overall portfolio holdings.

Number of Shares
504
Holding current value
$377,959
% of portfolio
0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$772.14 - $960.02 $389,158 - $483,850
504 New
504 $447,000
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $214,307 - $295,454
493 New
493 $271,000
Q3 2022

Dec 13, 2022

SELL
$296.48 - $337.87 $90,129 - $102,712
-304 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $44,450 - $51,415
304 New
304 $44,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Houlihan Financial Resource Group, Ltd. Portfolio

Follow Houlihan Financial Resource Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Houlihan Financial Resource Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Houlihan Financial Resource Group, Ltd. with notifications on news.